Condition
Barretts Esophagus With Low Grade Dysplasia
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Suspended1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04054713Not ApplicableSuspendedPrimary
Acetic Acid for the Detection of Esophageal Neoplasms
NCT06381583Completed
A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma
NCT03814824Not ApplicableCompleted
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
NCT04154748Not ApplicableCompletedPrimary
Argon Plasma Coagulation for Barrett's Esophagus
Showing all 4 trials